We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Photoacoustic Technology May Revolutionize Cancer Research

By LabMedica International staff writers
Posted on 13 Apr 2011
Innovative technology that combines the sensitivity of optical imaging with the resolution and depth penetration of high-frequency ultrasound will enable researchers to study cancer in its earliest stages of progression and evaluate tumor growth and the effect that potential drugs have on that growth.

The VisualSonics Inc. More...
(Toronto, Canada) Vevo LAZR uses a laser to shoot pulses of light through the skin into tissue and cells beneath the surface. The absorbed laser energy is then converted into heat, producing an ultrasonic emission, which can be captured and turned into images using a specially adapted high frequency ultrasonic probe. VisualSonics is a wholly owned subsidiary of SonoSite Inc. (Seattle, WA, USA).

The key to this novel approach is the capability of a wide range of biological materials to absorb laser light. Specific tissue components including oxyhemoglobin, deoxyhemoglobin, melanin, and lipids all absorb laser energy, which is then converted into heat that produces an ultrasonic emission that can be captured and turned into images using a specially adapted high frequency ultrasonic probe.

Applications for the Vevo LAZR system range from lymph node imaging to the study of hemoglobin and oxygen saturation and the targeted imaging of tumor biomarkers. In addition to cancer biology, this innovative technology will benefit other areas of life science research such as diabetes, neurosciences, and developmental and reproductive biology.

"The Vevo LAZR photoacoustics system is a breakthrough in vivo imaging technology,” said Anil Amlani president and CEO of VisualSonics. "Advancements featured in this product will enable oncology researchers to accelerate their research into understanding of the inner workings of the cancerous cell and the host tissue in which it resides. The ability to conduct this microscopic level research in a living organism, noninvasively and in real time will help our customers to turn groundbreaking science into lifesaving care, at an even greater speed.”

"We believe that the Vevo LAZR system will have a strong impact on the discovery of new cancer therapies, more efficient testing of therapies with never-before-seen insights into cancer, and quantified measures of cancer progression, viewed from inside the tumor,” said Kevin M. Goodwin, president and CEO of SonoSite. "With the launch of Vevo LAZR technology, we continue to meet our commitment to our customers by providing imaging technologies needed to further tomorrow's research today.”

Related Links:

VisualSonics Inc.
SonoSite Inc.



Gold Member
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Gram-Negative Blood Culture Assay
LIAISON PLEX Gram-Negative Blood Culture Assay
ESR Analyzer
TEST1 2.0
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The new analysis of blood samples links specific protein patterns to five- and ten-year mortality risk (Photo courtesy of Adobe Stock)

Blood Protein Profiles Predict Mortality Risk for Earlier Medical Intervention

Elevated levels of specific proteins in the blood can signal increased risk of mortality, according to new evidence showing that five proteins involved in cancer, inflammation, and cell regulation strongly... Read more

Hematology

view channel
Image: Research has linked platelet aggregation in midlife blood samples to early brain markers of Alzheimer’s (Photo courtesy of Shutterstock)

Platelet Activity Blood Test in Middle Age Could Identify Early Alzheimer’s Risk

Early detection of Alzheimer’s disease remains one of the biggest unmet needs in neurology, particularly because the biological changes underlying the disorder begin decades before memory symptoms appear.... Read more

Microbiology

view channel
Image: The SMART-ID Assay delivers broad pathogen detection without the need for culture (Photo courtesy of Scanogen)

Rapid Assay Identifies Bloodstream Infection Pathogens Directly from Patient Samples

Bloodstream infections in sepsis progress quickly and demand rapid, precise diagnosis. Current blood-culture methods often take one to five days to identify the pathogen, leaving clinicians to treat blindly... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.